CSOP Hang Seng Biotech Index ETF (03174.HK) fell 0.85%, with the latest price at HKD 3.520
The CSOP Hang Seng Biotech Index ETF (03174.HK) tracks the Hang Seng Biotech Index, which consists of listed companies in biotech, pharmaceuticals, and healthcare sectors in Hong Kong. The index is weighted by free-float market capitalization, reflecting the overall performance of Hong Kong's biotech sector.
NewTimeSpace Disclaimer: All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.
- PING AN(02318.HK): 2026 Q1 Report - Profit Attributable to Shareholders stood at CNY 25.02 billion, YoY decrease of 7.38%
- CNOOC(00883.HK): 2026 Q1 Report - Profit Attributable to Shareholders stood at CNY 39.14 billion, YoY increase of 7.06%
- YANKUANG ENERGY(01171.HK): 2026 Q1 Report - Profit Attributable to Shareholders stood at CNY 3.95 billion, YoY increase of 42.14%
- WUXI APPTEC(02359.HK) closed 13.57% higher, closing at HKD 143.1
- DACHAN FOOD(03999.HK): 2026 Q1 Report - Profit Attributable to Shareholders stood at CNY 3.62 million, turned profitable from a loss YoY
